How Influenza Vaccinations Can Protect High Risk Populations Of Diabetics & COPD

Speciality: All Speciality


Speaker:

Dr. Marco Goeijenbier | M.D., Vice Chair - European Scientist Working on Influenza international congress Board Member - European Scientist Working on Influenza(ESWI)

Description:

A warm welcome to all the medical professionals in this interesting session on the  benefits of influenza vaccination in high risk populations of diabetes and COPD patients. In this webinar, Dr. Marco Goeijenbier has shared the insights on the benefits of influenza vaccination in high risk populations.

Influenza is responsible for multiple deaths and about 20 to 30% of the deaths occurring annually are observed in children depicting the poor condition of controlling influenza in children. The virus is present globally but is not that powerful to create an epidemic.

Influenza is a contagious infection in nature causing high fever, body aches, cough, and other symptoms. Basically the children suffer for less than a week with the flu, but in cases of serious illness, they may need to be admitted to the hospital.

Among people with diabetes and chronic lung disease like COPD influenza causes severe impacts and flu vaccination has been shown to be associated with reduced hospitalizations from a worsening of their chronic condition. Flu vaccinations can shorten the length of hospital stay due to flu, reduce the risk of ICU admission from flu and also helps in reducing the risk of death from flu. 

Therefore,  get an overall knowledge regarding the  benefits of influenza vaccination in high risk populations of diabetes and COPD patients. 

 

See More Webinars @ Hidoc Webinars

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

2.

Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.

3.

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

4.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

5.

When does a melanoma metastasize? Implications for management


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot